[Skip to Content]
[Skip to Content Landing]
Views 912
Citations 0
Invited Commentary
February 2018

Strategies to Achieve High-Value Oncology Care—A Beginning

Author Affiliations
  • 1Patient-Centered Outcomes Research Institute, Washington, DC
  • 2Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill
  • 3Institute for Healthcare Improvement, Cambridge, Massachusetts
JAMA Oncol. 2018;4(2):171-172. doi:10.1001/jamaoncol.2017.3794

Cancer care is costly for individuals and in the aggregate. In one study, insured patients with advanced cancer reported median monthly out-of-pocket treatment expenditures of $592.1 In the aggregate, US expenditures for cancer care were $127 billion in 2013, which was 7% of total health care expenditures.2 These costs are projected to be at least $158 billion in 2020.3 Cancer care contributed 6.5% of the growth in health expenditures from 2000 to 2013. Circulatory diseases provide an informative contrast: disability-adjusted life-years have shrunk nearly 20% from 2005 to 2010 while annual expenditures have increased 7%. For cancer, the same figures are 12% and 26%, respectively.2

×